Levohypropizine

✨ ‌Metoclopramide Monohydrochloride Monohydrate (CAS 54143-57-6) | USP/EP-Certified Gastroprokinetic & Antiemetic Agent‌ ✨

🧪 ‌Product Overview‌

‌Metoclopramide Monohydrochloride Monohydrate‌ (CAS 54143-57-6) is a high-purity ‌dopamine D2 receptor antagonist‌ and ‌prokinetic drug‌ with the molecular formula ‌C₁₄H₂₅Cl₂N₃O₃‌ and a molecular weight of ‌354.27‌. This white crystalline powder (purity ≥99%) is widely utilized to enhance gastrointestinal motility, prevent nausea/vomiting, and treat gastroparesis. It acts by accelerating gastric emptying and increasing lower esophageal sphincter pressure, achieving clinical effects within ‌15–30 minutes‌ of administration‌12.

‌Key Functions‌:

• Stimulates upper GI motility for conditions like gastroparesis.

• Reduces chemotherapy-induced and postoperative vomiting.

• Serves as a reference standard in pharmaceutical quality control.

‌Target Industries‌: Pharmaceutical manufacturing, hospitals, and clinical research.

⭐ ‌Key Advantages‌

🏭 ‌Applications‌

• ‌Gastrointestinal Disorders‌: Treatment of diabetic gastroparesis, reflux esophagitis, and functional dyspepsia‌.

• ‌Oncology Support‌: Management of chemotherapy-induced nausea and vomiting.

• ‌Postoperative Care‌: Prevention of delayed gastric emptying after surgery.

📊 ‌Quality Assurance‌

• ‌Certifications‌: Complies with ‌USP/EP‌ pharmacopeial standards and ‌ISO 9001‌

• ‌Testing‌: Validated via HPLC, NMR, and FTIR spectroscopy.

• ‌Packaging‌: Available in ‌25kg‌ bulk drums or custom R&D batches (1g–10kg).

📈 ‌Market Insights‌

The global gastrointestinal drugs market is projected to grow at ‌4.9% CAGR (2025–2030)‌, driven by rising demand for antiemetics and prokinetics in chronic disease management. Metoclopramide remains a cost-effective first-line therapy, with ‌Asia-Pacific‌ leading production due to expanding generic drug manufacturing‌2.